Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
NEJM evidence(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined